ArticleAvicenna journal of medical biotechnology

Antibodies Produced Toward Recombinant RBD and Nucleocapsid Neutralize SARS-COV-2.

Amir Rezaei et al.PubMed ↗Full text ↗

No numbers read from the abstract.